UCL-TB

Watch the video of our recent World TB Day Symposium 2025. Details at www.ucl.ac.uk/tb/events/wo... @tb-lshtm.bsky.social

Did you miss @tb-lshtm.bsky.social & @ucltb.bsky.social Symposium? Or would you like to watch again? Good news: the full recording is now available! tinyurl.com/bdh8fymx
@sedonasweeney.bsky.social @kchorton.bsky.social @reinhouben.bsky.social

Tuberculosis in the UK Multipronged action is needed to reverse rising rates Tuberculosis (TB) is the world’s oldest pandemic, accounting for around a billion deaths in the past two centuries.1 In the UK, after more than a...

Last month we held a webinar on 'TB in the UK'. 500 people turned out to join the discussion. Read some of what we heard in this week's BMJ editorial piece www.bmj.com/content/388/.... #tuberculosis

Scaling-up symptom-agnostic, community-wide screening towards global tuberculosis elimination: opportunities, challenges and lessons from history Globally in 2023, 8.2 million people with a new episode of tuberculosis (TB) were diagnosed and notified.[1] This is the highest number of TB notifications for a single year since the World Health Org...

Out today: The need to scale up community-wide screening for TB irrespective of symptoms, if we are serious about ending TB. ijidonline.com/article/S120... @mrcctu.bsky.social

Today: Online link for World TB Day symposium 9-5 GMT: lshtm.zoom.us/j/92519123639. Programme information at ucl.ac.uk/tb/events/wo...

1 week today until our World TB Day Symposium! Join us in-person (more tickets available) or online.

Video now online for 'TB in the UK' webinar youtube.com/watch?v=h5Lp... #tuberculosis

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbek... Treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB) and pre–extensively drug-resistant TB using 24-week all-oral bedaquiline, pretoman

Excellent work by @msf.ca @msfsci.bsky.social, @who.int, Uzbekistan and Belarusian colleagues on real world evidence for #BPaLM and #BPaLC 6 months treatment for rifampicin-resistant #TB @lshtmamrcentre.bsky.social @ucltb.bsky.social

Person-Centred Care for TB-affected Households symposium
- Tomorrow 11th Feb, 1230-1400 GMT
- Hybrid, no registration required
www.ucl.ac.uk/tb/person-ce...

Join our "Person-Centred Care for TB-affected Households" hybrid symposium www.ucl.ac.uk/tb/person-ce... #tuberculosis
- Tues 11 Feb 2025, 1230-1400 GMT
- No pre-registration needed

Why is TB incidence in the UK on the rise? Join our free webinar on 'TB in the UK' to hear major stakeholders discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...

"Person-Centred Care for TB-affected Households": hybrid symposium
11 Feb 2025, 1230-1400 GMT no pre-registration
www.ucl.ac.uk/tb/person-ce... #tuberculosis

After falling for 10 years, TB incidence in the UK is on the rise. Join our free webinar on 'TB in the UK' to discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...

After falling for 10 years, TB incidence in the UK is on the rise. Join our free webinar on 'TB in the UK' to discuss why this is happening, and how we can best respond. Thurs 6th Feb, 3-5pm www.ucl.ac.uk/tb/tb-uk-web...

In-person London seminar on TB comorbidities by Prof Jonathan Golub next Wed 15th January at 1730 GMT www.ucl.ac.uk/tb/seminar-t... #tuberculosis

In-person London seminar on TB comorbidities by Prof Jonathan Golub next Wed 15th January at 1730 GMT hosted by Prof Lele Rangaka www.ucl.ac.uk/tb/seminar-t... #tuberculosis

Bedaquiline: what might the future hold? Tuberculosis drug development has stagnated for decades, so the recent availability of bedaquiline is welcome. Bedaquiline-containing regimens, now th…

Bedaquiline has been a great development in the treatment of drug-resistant TB. But it's future is uncertain due to rising resistance levels. Great review here.... #IDSky #Microsky #Infectiousdiseases #TB #Tuberculosis
www.sciencedirect.com/science/arti...

Thanks for this beautiful 🧵!
Wonderful to work with @gpollara.bsky.social
@helgardclaassen.bsky.social and @maphemthembu.bsky.social on this. Appreciate the support from @niaidnews.bsky.social @ahri-news.bsky.social and @ucltb.bsky.social. 3rd and final PhD paper for Maphe! 🎉 💫

TB-CHAMP, VQUIN, and the first effective treatment to prevent multidrug-resistant tuberculosis In September 2024, the World Health Organization (WHO) released new guidance on preventative treatment for tuberculosis (TB). Thanks to new evidence from two randomised controlled clinical trials, the

Today at the #UnionConf2024, Trinh Duong discussed safety of and adherence to levofloxacin to prevent multidrug-resistant #tuberculosis in the TB-CHAMP & VQUIN trials.

Get the full story behind these #TB trials on our podcast. Listen now👇
https://buff.ly/4euqqTG
#MedSky #IDSky @ucltb.bsky.social

DR-TPT webinar video now available. The edited recording of our webinar event on 'Preventive therapy for drug-resistant tuberculosis' can be seen here: youtube.com/watch?v=iyPx... @mrcctu.bsky.social